https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-01 / Gan To Kagaku Ryoho 2008 Jun;35(6):926-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-01 / Gan To Kagaku Ryoho 2008 Jun;35(6):926-302008-06-01 00:00:002019-02-15 08:59:42[Immunotherapy for glioma]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-15 / Clin. Cancer Res. 2008 May;14(10):3098-104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-15 / Clin. Cancer Res. 2008 May;14(10):3098-1042008-05-15 00:00:002021-11-15 14:47:03Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-04-15 / Int. J. Cancer 2008 Apr;122(8):1794-802
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-04-15 / Int. J. Cancer 2008 Apr;122(8):1794-8022008-04-15 00:00:002019-02-15 08:59:45Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-04-09 / Trends Mol Med 2008 May;14(5):228-35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-04-09 / Trends Mol Med 2008 May;14(5):228-352008-04-09 00:00:002019-02-15 08:46:53Cell- and peptide-based immunotherapeutic approaches for glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-03-28 / Cancer Immunol. Immunother. 2008 Dec;57(12):1745-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-03-28 / Cancer Immunol. Immunother. 2008 Dec;57(12):1745-562008-03-28 00:00:002019-02-15 08:59:42Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-03-04 / Radiother Oncol 2008 Mar;86(3):435-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-03-04 / Radiother Oncol 2008 Mar;86(3):435-422008-03-04 00:00:002019-02-15 08:59:43Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / J Clin Neurosci 2008 Feb;15(2):114-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / J Clin Neurosci 2008 Feb;15(2):114-212008-02-01 00:00:002019-02-15 08:59:48Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Neurosci Bull 2008 Feb;24(1):39-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Neurosci Bull 2008 Feb;24(1):39-442008-02-01 00:00:002019-02-15 08:59:46Dendritic cell-based immunotherapy for malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Rev Recent Clin Trials 2008 Jan;3(1):10-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Rev Recent Clin Trials 2008 Jan;3(1):10-212008-01-01 00:00:002019-02-15 08:46:52Dendritic cell immunotherapy for malignant gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-19 / J Transl Med 2007 Dec;5:67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-19 / J Transl Med 2007 Dec;5:672007-12-19 00:00:002019-02-15 08:59:44Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas
